Menu

Obama Backs Science

In a recent speech, the President defended spending on science and the peer-review process.

May 1, 2013
Edyta Zielinska

WIKIMEDIAIn a speech at the National Academy of Sciences (NAS) annual meeting this week (April 29), President Obama restated his support for research funding and his trust in the peer-review system, which has come under attack in recent weeks.

“With the pace of technological innovation today, we can't afford to stand still for a year or 2 years or 3 years,” Obama said, according to an NAS press release.

The comments come in response to a recent barrage of questions from republican leaders in Congress regarding the validity of specific grants and the peer-review process in general. Most recently, Republican Representative Lamar Smith from Texas, chairman of the Science, Space, and Technology Committee, circulated a proposal that suggested grants approved by the NSF should be certified by the agency director as advancing “national health, prosperity, or welfare, and to secure the national defense,” among other requirements.

Without naming names, the President responded to some of these efforts by saying, “I will keep working to make sure that our scientific research does not fall victim to political maneuvers or agendas that in some ways would impact on the integrity of the scientific process.”

But Obama’s speech wasn’t focused exclusively on politics. Some time was spent lauding the work of researchers and the NAS, as well throwing in a few zingers: “[P]art of what's made the Academy so effective is that all the scientists elected to your elite ranks are volunteers,” he said, according to ScienceInsider. “Which is fortunate because we have no money anyway.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.